Some of Tuesday's midday movers:» Read More
Nate Gross, Rock Health co-founder, discusses his company's efforts to revolutionize health care via the Internet.
CNBC's Seema Mody rounds up all the action surrounding Facebook's debut on the Nasdaq today.
Is the Facebook IPO good for the economy? Andrew Rachleff, Wealthfront president & CEO and David Callahan, Demos, weigh in.
Reacting to Facebook's first day of trading and forecasting its performance next week, with Russ Koesterich, BlackRock's iShares and the "Closing Bell" crew.
Facebook stock closed above its IPO price on its first day on the Nasdaq, with Richard Laermer, ThankBank CEO. "This is people who don't want to be a part of the hype, but on Monday, they will want to be part of the hype," Laermer says.
Facebook set a record for volume on its first day of trading, but the stock otherwise failed to live up to all the hype.
CNBC's David Faber reports on the performance of Facebook on its first day of trading on the Nasdaq.
David Pearl, Epoch Investment Partners and Jason Thomas, Aspirant, discuss Facebook's first day of trading; and CNBC's Melissa Lee reports Morgan Stanley and JPMorgan, top underwriters of the IPO deal, were heavy on this stock today to defend its $38 level.
CNBC's Bertha Coombs and Kayla Tausche explain Facebook's "sentiment barometer."
Sharing perspective on Facebook's performance on the Nasdaq today and whether judgments on the stock are premature, with James Bianco, Bianco Research president and CNBC Contributor Zachary Karabell.
Barry Sine, Drexel Hamilton and Paul Miller, FBR Capital Markets, share their take on JPMorgan as the charts tumble amid trading losses; and discussing Facebook's IPO, Sine says, "This is an IPO that doesn't work and if it hasn't worked the first day, then I don't think it's going to work."
Facebook's perceived lackluster debut has cast a shadow over social media stocks, reports CNBC's Seema Mody.
The "Closing Bell" crew discusses the frenzy surrounding Facebook's first trading day on the Nasdaq, with John Spallanzani, GFI Group and Peter Sorrentino, Huntington Asset Advisors.
You’ve probably heard 99 reasons why Facebook is ahead of the pack. But top money pro Roger McNamee tells us you only need to know about one.
CNBC's Bertha Coombs reports on how Facebook is trading since its IPO and its impact on Zynga, Apple and the Nasdaq Index. CNBC's Brian Shactman also offers insight into the "diaries" of other big tech IPOs and their growth over the years.
Tim Seymour, EmergingMoney.com founder, shares his take on Facebook's first day of trading and discusses how the IPO is impacting markets around the globe.
Jim McCaughan, Principal Global Investors CEO, shares perspective on Facebook's first day of trading and Europe's debt crisis. "It's most likely that [Facebook] won't fulfill the growth dreams that growth stock investors have," he says.
Brian Wieser, Pivotal Research, discusses his company's "sell" rating on Facebook and $820 price target on Google.
Discussing the hype around Facebook's IPO and explaining the confusion over whether investors "got what they wanted," with Ken Kamen, Mercadien Asset Management president and CNBC's Gary Kaminsky. CNBC's Bertha Coombs also reports Facebook execution messages have now been delivered.
CNBC's "Street Signs" crew explains Nasdaq's trading glitches today amid Facebook's IPO and also Mark Zuckerberg's statement.